Applied Clinical Trials-10-01-2014

News
Applied Clinical Trials

October 01, 2014

The rush is on to develop new therapies and vaccines to combat the lethal outbreak.

Applied Clinical Trials
CTI Insights

October 01, 2014

Research shows that the potential of integrated alliances remains elusive in the near term.

Applied Clinical Trials
A Closing Thought

October 01, 2014

The technology necessary to meet the expected regulatory demands for assessing drug-impaired driving has emerged.

View from Brussels
Applied Clinical Trials

October 01, 2014

Reshuffling to heavily impact life sciences policy in Europe.

News
Applied Clinical Trials

October 01, 2014

A Medical Technology Working Party is established to promote collaboration and dialogue on the specific aspects of clinical standards.

Applied Clinical Trials

Exploring sourcing model options for appropriate incorporation of DMCs into a clinical program.

Applied Clinical Trials

The distribution of locations for all trials registered on ClinicalTrials.gov.

Applied Clinical Trials

October 01, 2014

S

Applied Clinical Trials
Feature Article

October 01, 2014

Proving a biosimilar's pharmacokinetic 'equivalence' requires adherence to several unique factors.

Applied Clinical Trials

A systematic approach for early identification of BP effects during development of new drugs.

Issue PDF
Applied Clinical Trials

October 01, 2014

Trial Design: Identify Blood Pressure Effects Early Demonstrating Biosimilarity CRO/Sponsor: Data Monitoring Committee Users Guide Also in this issue: EU Reshuffling Impacts Pharma "Open Integration" Promise Elusive Assessing Drug-Impaired Driving